Litigation Details for AbbVie Inc. v. Aurobindo Pharma Ltd. (D. Del. 2014)
✉ Email this page to a colleague
AbbVie Inc. v. Aurobindo Pharma Ltd. (D. Del. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-02-18 |
| Court | District Court, D. Delaware | Date Terminated | 2014-04-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,136,799; 6,361,758 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AbbVie Inc. v. Aurobindo Pharma Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for AbbVie Inc. v. Aurobindo Pharma Ltd. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-02-18 | 1 | infringement of U.S. Patent Nos. 5,597,815 (“the ’815 patent”); 6,136,799 (“the ’799 patent”); and 6,361,758…civil action for patent infringement and declaratory judgment arising under the patent laws of the United…rights in the ʼ815 patent to WARF. AbbVie is the exclusive licensee of the ʼ815 patent. …of the ’799 patent is attached hereto as Exhibit B. 14. The ’799 patent expires on …of the ’758 patent is attached hereto as Exhibit C. 16. The ’758 patent expires on | External link to document | |
| 2014-02-18 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,136,799; 6,361,758 B1; 5,597,815…2014 29 April 2014 1:14-cv-00215 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
